M. Montoya

Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors.

L. Meijer, A. Monge, I. Aldana, 2002, Bioorganic & medicinal chemistry.

Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.

I. Tirapu, A. Monge, I. Aldana, 2001, Die Pharmazie.

Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.

A. López de Cerain, A. Monge, M. A. Ortega, 1998, Farmaco.

New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.

A. López de Cerain, A. Monge, M. A. Ortega, 2000, European journal of medicinal chemistry.

Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.

A. López de Cerain, A. Monge, M. A. Ortega, 1999, Die Pharmazie.

New Quinoxaline 1,4-Di-N-oxides for Treatment of Tuberculosis

A. López de Cerain, A. Monge, M. A. Ortega, 1999, Arzneimittelforschung.

Nutritional and food protection against epidemic emerging neuropathy. Epidemiological findings in the unique disease-free urban area of Cuba.

J. Arnaud, J. Barnouin, M. Chassagne, 2001, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.

A. López de Cerain, A. Monge, Y. Sainz, 1998, Farmaco.